Jeevan Scientific Technology Ltd

JSTL

Watchlist

AI Mode

‌

Market Cap

₹ 97 Cr

P/E

—

‌

‌
‌

‌

‌
‌

Investment Checklist

How to read checklist?

Performance

STEADY PERFORMER

Valuation

REASONABLE

Growth

SLUGGISH

Profitability

LOW MARGIN

Technicals

Bullish

Risk

MODERATE RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Jeevan Scientific Technology Ltd is an independent clinical contract research organization (CRO) focusing on delivering technology-driven clinical research solutions globally.

Initially, the company diversified into product development for various industries like edible oil and hospital management, highlighting a broad operational scope.

In recent years, Jeevan Scientific has significantly expanded its clinical research capabilities, offering comprehensive services from bioavailability studies to full Phase I-IV trials.

The establishment of a bioanalytical lab and clinical pharmacology unit underscores the company's commitment to advancing its research infrastructure.

The divestment of subsidiaries Enhops Solutions Private Limited and Enhops Inc marks a strategic realignment, focusing on core operations in clinical research.

Sector

Healthcare

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

Market Cap

97 Cr

Volatility

Low Risk

P/E Ratio

—

Industry P/E

30.8

PEG Ratio

—

P/B Ratio

2.1

52W High

66.90

52W Low

32.85

Sales CAGR

18.13%

-8.30%

16.22%

10Y

10.79%

Profit CAGR

104.51%

-60.85%

—

10Y

6.44%

ROE

TTM

-9.29%

-2.24%

8.60%

10Y

4.59%

ROCE

TTM

-5.26%

-0.80%

12.39%

10Y

8.70%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
VAISHALI	8.04	105 Cr	—	1.56	0.00	-0.57	1.54	-0.32
ACCPL	90.85	101 Cr	14.87	2.24	0.00	19.50	25.71	15.37
JSTL	61.99	97 Cr	—	2.06	0.00	-9.29	-5.26	-5.27
CURIS	115.55	96 Cr	17.83	2.55	0.00	0.00	0.00	0.00
ASTALLTD	83.66	94 Cr	9.45	2.15	0.00	22.69	25.33	9.83
CONCORD	85.50	88 Cr	151.60	2.55	0.00	1.67	6.00	0.85
SOURCENTRL	130.50	87 Cr	29.33	3.68	0.00	12.56	15.10	7.35

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	10	8.06	10	11	13	11	13	10	8.80	12
Expenses	8.36	7.46	9.11	10	9.66	8.90	10	10	11	10
Operating Profit	2.03	0.60	1.02	0.98	3.22	2.50	2.08	-0.38	-1.78	2.07
OPM %	19.54	7.44	10.07	8.85	25.00	21.93	16.63	-3.78	-20.23	16.72
Other Income	0.30	0.26	-0.11	0.23	0.11	0.16	0.23	0.15	0.33	0.20
Interest	0.23	0.26	0.15	0.33	0.33	0.45	0.43	0.55	0.54	0.55
Depreciation	1.47	1.43	1.40	1.64	1.51	1.49	1.48	1.77	1.74	1.69
Profit Before Tax	0.63	-0.83	-0.64	-0.76	1.49	0.72	0.39	-2.55	-3.73	0.03
Tax %	19.05	26.51	25.00	3.95	31.54	65.28	89.74	50.59	13.67	66.67
Net Profit	0.51	-0.61	-0.49	-0.73	1.03	0.25	0.05	-1.26	-3.22	0.01
EPS in Rs	0.31	-0.38	-0.30	-0.46	0.65	0.16	0.03	-0.79	-2.03	0.01

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	18	20	26	24	47	68	36	40	47	43
Expenses	15	17	21	30	30	51	35	35	39	40
Operating Profit	3.07	3.42	5.46	-6.37	17	17	1.32	4.62	7.41	2.42
OPM %	16.84	16.75	20.90	-26.60	37.02	24.72	3.65	11.65	15.82	5.66
Other Income	0.58	0.92	1.00	2.53	2.39	5.92	1.07	0.67	0.65	0.87
Interest	1.41	1.86	1.97	2.79	2.16	0.96	1.00	0.97	1.76	1.97
Depreciation	1.23	2.12	3.13	3.92	3.97	3.69	5.07	5.93	6.25	6.48
Profit Before Tax	1.01	0.36	1.37	-11	14	18	-3.68	-1.60	0.05	-5.17
Tax %	10.62	69.12	18.42	18.56	13.99	33.75	16.78	17.25	-16.37	19.15
Net Profit	0.90	0.11	1.11	-8.59	12	12	-3.06	-1.33	0.06	-4.18
EPS in Rs	0.52	0.10	0.84	-5.43	7.46	7.67	-1.95	-0.83	0.04	-2.78
Dividend Payout %	0.00	0.00	0.00	0.00	6.49	15.94	0.00	0.00	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	6.04	9.28	11	15	15	15	15	15	15	16
Reserves	-2.27	7.60	11	17	7.92	20	35	33	33	34
Borrowings	11	7.21	17	15	15	10	13	10	13	21
Other Liabilities	5.87	6.81	10	15	15	21	15	7.64	6.03	7.77
Total Liabilities	20	31	49	61	54	66	78	66	68	78
Fixed Assets	8.67	16	28	33	31	27	19	25	27	35
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.90	2.81	4.71
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	12	15	21	29	23	39	59	39	38	39
Total Assets	20	31	49	61	54	66	78	66	68	78

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	3.55	-5.62	5.65	4.04	-0.01	4.95	20	-6.41	2.89	10
Cash from Investing Activity	-3.63	-8.90	-14	-7.87	-1.90	-0.80	-1.20	-6.93	-12	-16
Cash from Financing Activity	0.23	15	9.86	6.08	0.44	-0.13	5.67	-9.54	2.35	5.24
Net Cash Flow	0.15	0.05	1.17	2.25	-1.47	4.02	24	-23	-6.29	-0.30

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	36.85%	38.44%	38.48%	38.48%	38.48%	38.70%	38.70%	38.70%	37.84%	38.05%	38.05%	38.05%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	63.15%	61.56%	61.52%	61.52%	61.52%	61.30%	61.30%	61.30%	62.16%	61.95%	61.95%	61.95%
Total Shareholders	6,295	6,061	5,911	5,933	5,727	5,749	5,655	5,607	5,565	5,497	5,460	5,444

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Oct 15, 2025	Durisala desaiah	Bulk	Sell	52.16	2.61 Cr	5,00,000	3.15
Oct 15, 2025	Rampurhat psc sleepers limited	Bulk	Buy	52.94	0.61 Cr	1,15,000	0.72
Oct 15, 2025	Sheetal sharma	Bulk	Buy	52.00	0.47 Cr	90,000	0.56
Oct 13, 2025	Nandela gopalakrishna reddy	Bulk	Sell	50.20	2.51 Cr	5,00,000	3.15
Oct 13, 2025	Prity agarwal	Bulk	Buy	50.30	1.51 Cr	3,00,000	1.89
Oct 13, 2025	Akshat jajodia	Bulk	Buy	50.48	0.50 Cr	1,00,000	0.63
Oct 13, 2025	Rampurhat psc sleepers limited	Bulk	Buy	49.97	0.50 Cr	1,00,000	0.63
Mar 25, 2025	Jeevan krishna kuchipudi	Insider - Director	Acquisition	41.39	0.05 Cr	11,301	0.07
Mar 13, 2025	Jeevan krishna kuchipudi	Insider - Director	Acquisition	44.57	0.10 Cr	22,366	0.14
Mar 29, 2024	Krishna kishore kuchipudi	Insider - Promoter & Director	Acquisition	46.32	0.02 Cr	3,985	0.02

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	10	8.06	10	11	13	11	13	10	8.80	12
Expenses	8.36	7.46	9.11	10	9.66	8.90	10	10	11	10
Operating Profit	2.03	0.60	1.02	0.98	3.22	2.50	2.08	-0.38	-1.78	2.07
OPM %	19.54	7.44	10.07	8.85	25.00	21.93	16.63	-3.78	-20.23	16.72
Other Income	0.30	0.26	-0.11	0.23	0.11	0.16	0.23	0.15	0.33	0.20
Interest	0.23	0.26	0.15	0.33	0.33	0.45	0.43	0.55	0.54	0.55
Depreciation	1.47	1.43	1.40	1.64	1.51	1.49	1.48	1.77	1.74	1.69
Profit Before Tax	0.63	-0.83	-0.64	-0.76	1.49	0.72	0.39	-2.55	-3.73	0.03
Tax %	19.05	26.51	25.00	3.95	31.54	65.28	89.74	50.59	13.67	66.67
Net Profit	0.51	-0.61	-0.49	-0.73	1.03	0.25	0.05	-1.26	-3.22	0.01
EPS in Rs	0.31	-0.38	-0.30	-0.46	0.65	0.16	0.03	-0.79	-2.03	0.01

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	18	20	26	24	47	68	36	40	47	43
Expenses	15	17	21	30	30	51	35	35	39	40
Operating Profit	3.07	3.42	5.46	-6.37	17	17	1.32	4.62	7.41	2.42
OPM %	16.84	16.75	20.90	-26.60	37.02	24.72	3.65	11.65	15.82	5.66
Other Income	0.58	0.92	1.00	2.53	2.39	5.92	1.07	0.67	0.65	0.87
Interest	1.41	1.86	1.97	2.79	2.16	0.96	1.00	0.97	1.76	1.97
Depreciation	1.23	2.12	3.13	3.92	3.97	3.69	5.07	5.93	6.25	6.48
Profit Before Tax	1.01	0.36	1.37	-11	14	18	-3.68	-1.60	0.05	-5.17
Tax %	10.62	69.12	18.42	18.56	13.99	33.75	16.78	17.25	-16.37	19.15
Net Profit	0.90	0.11	1.11	-8.59	12	12	-3.06	-1.33	0.06	-4.18
EPS in Rs	0.52	0.10	0.84	-5.43	7.46	7.67	-1.95	-0.83	0.04	-2.78
Dividend Payout %	0.00	0.00	0.00	0.00	6.49	15.94	0.00	0.00	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	6.04	9.28	11	15	15	15	15	15	15	16
Reserves	-2.27	7.60	11	17	7.92	20	35	33	33	34
Borrowings	11	7.21	17	15	15	10	13	10	13	21
Other Liabilities	5.87	6.81	10	15	15	21	15	7.64	6.03	7.77
Total Liabilities	20	31	49	61	54	66	78	66	68	78
Fixed Assets	8.67	16	28	33	31	27	19	25	27	35
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.90	2.81	4.71
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	12	15	21	29	23	39	59	39	38	39
Total Assets	20	31	49	61	54	66	78	66	68	78

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	3.55	-5.62	5.65	4.04	-0.01	4.95	20	-6.41	2.89	10
Cash from Investing Activity	-3.63	-8.90	-14	-7.87	-1.90	-0.80	-1.20	-6.93	-12	-16
Cash from Financing Activity	0.23	15	9.86	6.08	0.44	-0.13	5.67	-9.54	2.35	5.24
Net Cash Flow	0.15	0.05	1.17	2.25	-1.47	4.02	24	-23	-6.29	-0.30

Oscillators

BearishNeutralBullish

Neutral

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Overview

Detailed Summary

Jeevan Scientific Technology Ltd is an independent clinical contract research organization (CRO) focusing on delivering technology-driven clinical research solutions globally.

Initially, the company diversified into product development for various industries like edible oil and hospital management, highlighting a broad operational scope.

In recent years, Jeevan Scientific has significantly expanded its clinical research capabilities, offering comprehensive services from bioavailability studies to full Phase I-IV trials.

The establishment of a bioanalytical lab and clinical pharmacology unit underscores the company's commitment to advancing its research infrastructure.

The divestment of subsidiaries Enhops Solutions Private Limited and Enhops Inc marks a strategic realignment, focusing on core operations in clinical research.

Sector

Healthcare

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

Market Cap

97 Cr

Volatility

Low Risk

P/E Ratio

—

Industry P/E

30.8

PEG Ratio

—

P/B Ratio

2.1

52W High

66.90

52W Low

32.85

Sales CAGR

18.13%

-8.30%

16.22%

10Y

10.79%

Profit CAGR

104.51%

-60.85%

—

10Y

6.44%

ROE

TTM

-9.29%

-2.24%

8.60%

10Y

4.59%

ROCE

TTM

-5.26%

-0.80%

12.39%

10Y

8.70%

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
VAISHALI	8.04	105 Cr	—	1.56	0.00	-0.57	1.54	-0.32
ACCPL	90.85	101 Cr	14.87	2.24	0.00	19.50	25.71	15.37
JSTL	61.99	97 Cr	—	2.06	0.00	-9.29	-5.26	-5.27
CURIS	115.55	96 Cr	17.83	2.55	0.00	0.00	0.00	0.00
ASTALLTD	83.66	94 Cr	9.45	2.15	0.00	22.69	25.33	9.83
CONCORD	85.50	88 Cr	151.60	2.55	0.00	1.67	6.00	0.85
SOURCENTRL	130.50	87 Cr	29.33	3.68	0.00	12.56	15.10	7.35